Beth Anne Jones, PhD, MPH
Cards
Additional Titles
Inaugural Director, Cancer Screening & Prevention Program
Contact Info
Chronic Disease Epidemiology
Center for Cancer Prevention Research, 1 Church Street
New Haven, CT 06510
United States
About
Titles
Research Scientist in and Lecturer in Epidemiology (Chronic Diseases)
Inaugural Director, Cancer Screening & Prevention Program
Biography
Dr. Jones is a Yale-trained cancer epidemiologist whose work and teaching focus is on health disparities. Her research is primarily focused on racial/ethnic differences in cancer screening, prevention, and cancer outcomes. A recently completed study tested 4 evidence-based interventions to address overdue colorectal cancer screening in a large urban primary care clinic. Ongoing projects include working with Implementation Science research teams to address system and patient level factors that compromise the full benefit of cervical cancer screening in minority populations and in developing mitigation strategies to protect respiratory health in large clinical workplace. Other projects focus on the impact of COVID-19 on adults and GEN-Z populations in at-risk communities with implications for cancer prevention and screening behaviors.
In leadership roles in Community Outreach Education efforts for the Yale Comprehensive Cancer Center and as inaugural Director of Smilow Cancer Hospital's Cancer Screening & Prevention Program, Dr. Jones has led a number of programmatic efforts to engage underserved communities in cancer prevention and screening activities throughout a large catchment area. Using best community practices, adapted due to recent pandemic, we created a platform for reaching nearly 100,000 community members per year with vetted, evidence-based health prevention and screening messages in Spanish and English languages, launched a community facing navigation program that screened and addressed social determinants of health (SDOH) barriers, and are now adapting some of these strategies to engage traditionally under-served populations on the important role of cancer related genetic testing in a large health system.
These translational efforts are a natural outgrowth of her population-based studies of mammography screening and other health behaviors, breast density, and colorectal cancer screening in Hispanic/Latinas and African American/Black women living in the Northeast, US. Using a multidisciplinary approach, she has also evaluated the role(s) of obesity, tumor characteristics, selected genetic alterations and genetic polymorphisms, as well as social class, medical care, and psychosocial factors, in explaining differences cancer stage at diagnosis and survival between African Americans and Whites in breast, prostate, and colorectal cancer.
Appointments
Chronic Disease Epidemiology
Research ScientistPrimaryChronic Disease Epidemiology
LecturerSecondary
Other Departments & Organizations
Education & Training
- PhD
- Yale University, Epidemiology (1993)
- MPH
- Yale School of Public Health, Epi / Health Services
Research
Overview
Cancer Disparities
- Mammography Screening in African American and White women
- Cancer Screening Behavior in Hispanic/Latinas Living in the Northeast United States
- Racial / ethnic differences in tumor characteristics
- Race Differences and Breast Density
- Yale Cancer Disparities Firewall: Community Engagement, Health Education, and Health Navigation to Promote Cancer Prevention and Screening in At-Risk Populations
- Implementing Colorectal Cancer Screening in Vulnerable Populations in the FQHC setting
- Community Engagement to Promote Cancer Screening, Cancer Prevention and Minority Participation in Clinical Trials
- CURE Award: Cancer Research Opportunities for Youth at Yale
- Covid-19 and Social Determinants of Health (SDOH): Impact on Vulnerable Populations
- Covid-19 and Social Determinants of Health (SDOH): Impact on Gen Z Population
Medical Subject Headings (MeSH)
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Andrea Silber, MD
Brenda Cartmel, PhD
Courtney McGowan
Fangyong Li, MS, MPH
Lisa Calvocoressi, PhD
Maura Harrigan, MS, RDN, CSO
Breast Neoplasms
Social Class
Socioeconomic Factors
Health Status Disparities
Healthcare Disparities
Neoplasms
Publications
2023
Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study
Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li F, Ferrucci L, Puklin L, Cao A, Nguyen T, Neuhouser M, Hershman D, Basen-Engquist K, Jones B, Knobf T, Chagpar A, Silber A, Tanasijevic A, Ligibel J, Irwin M. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal Of Clinical Oncology 2023, 41: 5285-5295. PMID: 37656930, PMCID: PMC10691793, DOI: 10.1200/jco.23.00871.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsRelative dose intensityPathologic complete responseProportion of patientsBreast cancerNeoadjuvant chemotherapyChemotherapy completionComplete responseNutrition interventionsHigher pathologic complete responseHuman epidermal growth factor receptor 2Epidermal growth factor receptor 2Triple-negative breast cancerChemotherapy dose adjustmentsHome-based exerciseGrowth factor receptor 2Breast cancer outcomesEffects of exerciseFactor receptor 2Electronic medical recordsChi-square testUsual careDose intensityExercise interventionDose adjustmentRandomized trials
2022
Randomized trial of diet and exercise on chemotherapy completion in women with breast cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) study.
Sanft T, Harrigan M, Cartmel B, Li F, Zupa M, McGowan C, Ferrucci L, Puklin L, Nguyen T, Tanasijevic A, Neuhouser M, Hershman D, Basen-Engquist K, Jones B, Knobf M, Chagpar A, Silber A, Ligibel J, Irwin M. Randomized trial of diet and exercise on chemotherapy completion in women with breast cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) study. Journal Of Clinical Oncology 2022, 40: 12007-12007. DOI: 10.1200/jco.2022.40.16_suppl.12007.Peer-Reviewed Original ResearchCitationsAltmetricConceptsRelative dose intensityHigh relative dose intensityBreast cancerDose-response effectPhysical activityPA interventionsNeoadjuvant chemotherapyChemotherapy completionDiet qualityStage I breast cancerEndocrine therapy adherenceTrial of dietDifferent chemotherapy regimensI breast cancerBody mass indexPatient-reported outcomesHealthy Eating IndexBetter diet qualityHigh physical activityMore physical activityElectronic medical recordsChi-square testUC participantsChemotherapy regimensSecondary endpointsSocioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women.
de Almeida LM, Cortés S, Vilensky M, Valenzuela O, Cortes-Sanabria L, de Souza M, Barbeito RA, Abdelhay E, Artagaveytia N, Daneri-Navarro A, Llera AS, Müller B, Podhajcer OL, Velazquez C, Alcoba E, Alonso I, Bravo AI, Camejo N, Carraro DM, Castro M, Cataldi S, Cayota A, Cerda M, Colombo A, Crocamo S, Del Toro-Arreola A, Delgadillo-Cristerna R, Delgado L, Breitenbach MD, Fernández E, Fernández J, Fernández W, Franco-Topete RA, Gaete F, Gómez J, Gonzalez-Ramirez LP, Guerrero M, Gutierrez-Rubio SA, Jalfin B, Lopez-Vazquez A, Loria D, Míguez S, Moran-Mendoza AJ, Morgan-Villela G, Mussetti C, Nagai MA, Oceguera-Villanueva A, Reis RM, Retamales J, Rodriguez R, Rosales C, Salas-Gonzalez E, Segovia L, Sendoya JM, Silva-Garcia AA, Viña S, Zagame L, Jones B, Szklo M. Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women. Frontiers In Oncology 2022, 12: 845527. PMID: 35530311, PMCID: PMC9071365, DOI: 10.3389/fonc.2022.845527.Peer-Reviewed Original Research
2021
Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial
Sanft T, Harrigan M, Cartmel B, Ferrucci LM, Li FY, McGowan C, Zupa M, Nguyen TH, Ligibel J, Neuhouser ML, Hershman DL, Basen-Engquist K, Jones B, Knobf T, Chagpar A, Silber A, Irwin ML. Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial. Contemporary Clinical Trials 2021, 109: 106508. PMID: 34274495, PMCID: PMC10424280, DOI: 10.1016/j.cct.2021.106508.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsChemotherapy completion rateTreatment-related side effectsPhysical activity guidelinesBreast cancerActivity guidelinesCancer survivorsSide effectsWorld Cancer Research FundUsual care control groupCompletion ratesEndocrine therapy adherenceCare control groupHealthy lifestyle interventionRandomized clinical trialsPatient reported outcomesPhysical activity interventionsBreast cancer treatmentAmerican Cancer SocietyBreast cancer prognosisCancer Research FundElectronic medical recordsOncology nutritionTreating oncologistSecondary endpointsChemotherapy sessionRacial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors
Puthenpura V, Canavan ME, Poynter JN, Roth M, Pashankar FD, Jones BA, Marks AM. Racial/ethnic, socioeconomic, and geographic survival disparities in adolescents and young adults with primary central nervous system tumors. Pediatric Blood & Cancer 2021, 68: e28970. PMID: 33704901, PMCID: PMC8221084, DOI: 10.1002/pbc.28970.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHazard of deathCentral nervous system tumorsNervous system tumorsRace/ethnicitySocioeconomic statusSystem tumorsMultivariate Cox proportional hazards modelNon-Hispanic black patientsNon-Hispanic white patientsPrimary central nervous system tumorsCox proportional hazards modelEnd Results (SEER) databaseRetrospective cohort studyPrimary CNS tumorsYoung adult patientsNeuro-oncology patientsProportional hazards modelLowest SES tertileLow socioeconomic statusNHB patientsAYA patientsHazard ratioNHW patientsAdult patientsCohort study
2019
Knowledge of, and beliefs about, access to screening facilities and cervical cancer screening behaviors among low-income women in New Jersey
Silvera SAN, Bandera EV, Jones BA, Kaplan AM, Demisse K. Knowledge of, and beliefs about, access to screening facilities and cervical cancer screening behaviors among low-income women in New Jersey. Cancer Causes & Control 2019, 31: 43-49. PMID: 31720918, PMCID: PMC9083372, DOI: 10.1007/s10552-019-01244-5.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdultAgedCross-Sectional StudiesEarly Detection of CancerEthnicityFemaleHealth Knowledge, Attitudes, PracticeHealth Services AccessibilityHealth Status DisparitiesHealthcare DisparitiesHumansLogistic ModelsMass ScreeningMiddle AgedMultivariate AnalysisNew JerseyPapanicolaou TestPovertyRacial GroupsRiskUterine Cervical NeoplasmsVaginal SmearsYoung AdultConceptsLow-income womenCervical cancerCancer outcomesCervical cancer outcomesMultivariate logistic regressionCross-sectional studyPap testingPap testCancer screeningInsurance statusCancer testsPrevention strategiesEthnic disparitiesLogistic regressionSocioeconomic differencesCancerWomenAffordable screeningScreening facilityScreeningOutcomesRisk awarenessNew JerseyYearsSerious adverse events in African–American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort
Hoag JR, Andemariam B, Wang X, Gregorio DI, Jones BA, Sporn J, Salner AL, Swede H. Serious adverse events in African–American cancer patients with sickle cell trait and inherited haemoglobinopathies in a SEER-Medicare claims cohort. British Journal Of Cancer 2019, 120: 861-863. PMID: 30890774, PMCID: PMC6474269, DOI: 10.1038/s41416-019-0416-7.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsSickle cell traitAfrican American cancer patientsSerious adverse eventsAdverse eventsNon-Hispanic whitesCancer patientsRelative riskCell traitEmergency department visitsSEER-Medicare databaseDepartment visitsPrognostic impactAA patientsCancer outcomesWorse outcomesProstate cancerCohort analysisPatientsClaims cohortMagnitude of effectCancer typesAA populationHaemoglobinopathiesOutcomesRisk
2006
THE AUTHORS REPLY
Calvocoressi L, Stolar M, Kasl S, Claus E, Jones B. THE AUTHORS REPLY. American Journal Of Epidemiology 2006, 164: 401-402. DOI: 10.1093/aje/kwj236.Peer-Reviewed Original Research
2005
Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival
Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu H. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecologic Oncology 2005, 100: 330-337. PMID: 16199080, DOI: 10.1016/j.ygyno.2005.08.035.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsOvarian cancer treatmentDisease progressionGSTP1 genotypesGST polymorphismsPrimary epithelial ovarian cancerCox proportional hazards regressionFunctional polymorphismsGSTP1 Ile/IleCancer treatmentGSTP1 Ile/ValGlutathione S-transferase polymorphismsGSTM1 null patientsPost-operative chemotherapySubgroup of patientsProportional hazards regressionEpithelial ovarian cancerOvarian cancer survivalEffect of chemotherapyOvarian cancer prognosisOvarian cancer progressionVal/ValIle/IleIle/ValOverall survivalTumor characteristics524: Stressful Life Events and Adherence to Mammography Screening Guidelines among African-American and White Women
Soler-Vila H, Calvocoressi L, Kasl S, Jones B. 524: Stressful Life Events and Adherence to Mammography Screening Guidelines among African-American and White Women. American Journal Of Epidemiology 2005, 161: s131-s131. DOI: 10.1093/aje/161.supplement_1.s131c.Peer-Reviewed Original Research
Academic Achievements and Community Involvement
activity CT Multicultural Health Partnership, State of CT Dept of Public Health
Public ServiceMemberDetails2008 - Presentactivity President's Council on Cancer
CommitteesPresenter/SpeakerDetails2009 - Presenthonor Invited Testimony, The President’s Cancer Panel, America’s Demographic and Cultural Transformation: Implications for Cancer. Los Angeles, CA, Oct, 2009
National AwardHHS, NIH, NCI. President’s Cancer Panel Annual Report 2009-2010 (2011)Details10/01/2009United Stateshonor Member, Board of Directors
Regional AwardCommunity Health Action, Innovation and Networking, Inc. (CHAIN)Details01/01/2008United Statesactivity Office of the Elimination of Cancer Disparities, Yale Comprehensive Cancer Center
Professional OrganizationsDirectorDetails2006 - 2008
Links & Media
News
- June 13, 2022Source: NCI Community Research and Engagement
Yale Cancer Center Community Research and Engagement
- July 15, 2021
Doctoral Student Finds Calling in Data Analysis and Public Health
- February 10, 2021
Reducing Cancer Burden Through Collaborative Research
- May 21, 2020
Yale Cancer Disparities Firewall Project Receives Grants from the Bristol Myers Squibb Foundation to Fight COVID-19
Get In Touch
Contacts
Chronic Disease Epidemiology
Center for Cancer Prevention Research, 1 Church Street
New Haven, CT 06510
United States
Administrative Support
Locations
Center for Cancer Prevention Research
Academic Office
1 Church Street, Fl 2nd
New Haven, CT 06510
Business Office
203.737.5125